Lawsuit against Lance Armstrong Raises Novel Questions about the False Claims Act’s Reach

By Jonathan Cohn and Brian Morrissey of Sidley Austin LLP   Amid last week’s coverage of Tour de France-winning cyclist Lance Armstrong’s public acknowledgement that he used banned performance-enhancing substances during all of his Tour victories, numerous news outlets reported that Armstrong’s “doping” had also become the basis of a federal False Claims Act suit. The suit was brought under the FCA’s qui tam provisions by Armstrong’s former teammate, Floyd Landis, and alleges